Providence, Rhode Island, Oct. 17, 2023 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research scientists, today announced that its joint venture partner, Virion Therapeutics, LLC, is now enrolling patients in its Phase 1b study for a…Read More
Ocean Biomedical Inc Ocean Biomedical NASDAQ OCEA Announces Enrollment of Patients for Phase 1b Study for Chronic Hepatitis B Treatment in 5050 Joint Venture with Virion Therapeutics
